LATEST
NEWS

Aytu is suspending its trial - what's next?

Aytu Initiates vEDS Clinical Trial

New Treatment? New Hope for vEDS

2020 Review and Looking Ahead

The FDA rejects celiprolol - how should we interpret the news?

NEW STUDY: vEDS patients are living longer, but unclear what role celiprolol plays

Longer Life with vEDS: A Lesson from Marfan Syndrome

The 4 Essential Elements of your vEDS Care Team

A vEDS Confession...the 1st time I met another patient

2018 vEDS Collaborative Meeting: What to Expect

How much does the "v" mean to vEDS?

7 Lessons from the vEDS Facebook Community

FIGHT vEDS Version 2.0 Website Now Available!

300+ Patients Respond to University of Washington Research Survey

The University of Washington and FIGHT vEDS ask patients to set the research agenda

Congress Attempts to Alter the Orphan Drug Tax Credit

5 Tips from Benjamin Franklin for vascular EDS

Acer Therapeutics Obtains Exclusive License to Celiprolol Study Data